Program

13.00-13.45 Registration to the EURO MITT meeting 2025
13.45-14.00 Introduction
Welcome in France, welcome in Menton
Introduction Lecture

14.00-16.25 SESSION 1
BEFORE the procedure
1.1 Before the procedure: nodule and patient selection -
approaching the «zero risk»
14.00-14.10 The imaging (US & functional) issue
14.10-14.20 The cyto-histologic issue
14.20-14.30 The uncertainty issue
14.30-14.45 Discussion
14.45-14.55 Current indication benign disease
14.55-15.05 Current indication malignant disease
15.05-15.20 Discussion

1.2 Before the procedure: the techniques
15.20-15.30 RFA in 2025
15.30-15.40 Laser in 2025
15.40-15.50 MWA in 2025
15.50-16.00 nsPFA in 2025
16.00-16.15 Discussion
16.15-16.25 How to make your choice: take home messages

16.25-16.55 Coffee Break

16.55-19.15 SESSION 2
DURING the procedure
Room setting and patient management through clinical cases
16.55-17.15 Case 1 – Preprocedural workup is NOT an option
17.15-17.35 Case 2 - Anesthesia: from local infiltration and regional nerve block to musicare and hypnosis
17.35-17.55 Case 3 – A new watergate – focus on hydrodissection(s)
17.55-18.15 Case 4 – RFA – how I do it
18.15-18.35 Case 5 – Laser – how I do it
18.35-18.55 Case 6 – MWA – how I do it
18.55-19.15 Case 7 – Not only ablation: embolization for large goiters?

08.00-10.00 SESSION 3
Somewhere BETWEEN procedures and literature
3.1 Updates
08.00-08.10 Latest results in BTN
08.10-08.20 Discussion
08.20-08.30 Latest results in PTMC
08.30-08.40 Discussion
08.40-08.50 Recurrent and metastatic thyroid tumors
08.50-09.00 Discussion
3.2 Hot topics
09.00-09.10 Parathyroid ablation
09.10-09.20 Discussion
09.20-09.30 AFTN: when and how?
09.30-09.40 Discussion
09.40-09.50 The cost balance: MIT vs surgery
09.50-10.00 Discussion

10.00-10.30 Coffee Break

10.00-12.10 PLENARY SESSION 4
AFTER the procedure
4.1 Post-procedure evaluation
10.30-10.40 Clinical and US post-treatment evaluation: modalities and standardized report
10.40-10.50 Discussion
10.50-11.00 The use of 3D US for post-treatment evaluation
11.00-11.10 Discussion
11.10-11.20 Complications: management of pain, voice changes,
local bleeding and nodular rupture
11.20-11.30 Discussion
4.2 The universe of relapse, regrowth and retreatment
11.30-11.40 Relapse, regrowth, retreatment: risk factors and prediction
11.40-11.50 Discussion
11.50-12.00 Relapse, regrowth, retreatment:
practical management - curative and preventive strategies
12.00-12.10 Discussion

12.10-13.15 Closing the meeting with our partners and perspectives
12.30-13.00 INDUSTRY FOCUS
13.00-13.15 Presentation of EURO-MITT and perspectives
 

PRE-CONGRESS COURSE
Advanced Ultrasound Course
FROM NODULE SELECTION TO INTERVENTIONAL PROCEDURES
VIA PERCUTANEOUS ETHANOL INJECTION
Small Groups (Participants will be divided into small groups, reproducing the expert approach with dedicated proctors)
08.00-08.30 Registration
08.45-09.00 Introduction to the course and pre-test
09.00-10.00 Revisiting the ultrasound (US) workup for thyroid nodules candidate to MITT (Hands-on)
> Echo-anatomy: identification of danger zones, nerves and plexis,
vessels, normal parathyroid
> Lymph nodes
> Pitfalls and variants
10.00-11.00 Clinical cases: is this patient eligible for MITT?
(Clinical vignettes and Interactive Quiz)
11.00-12.30 PERCUTANEOUS ETHANOL INJECTION
> How I do it (video lecture)
> HANDS ON (dummies): 10 min. per person



 

HANDS ON COURSE 1
14.00-16.30 Thermal ablation
25 participants
Participants will have the opportunity to perform ablation on dedicated phantoms with different ablation systems on various stations





 

Friday, 7th February, 2025